Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jun-20 5:14 PM View:  | Charles River Laboratories ... (CRL) | 29-May-20 | Grant | 557 | -- | -- | < 1% 223.92K to 224.48K | |
| 26-Feb-20 12:24 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-20 | Payment of Exercise | 727 | $162.46 | $118,108.00 | (< 1%) 224.65K to 223.92K | |
| 24-Feb-20 12:18 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-20 | Payment of Exercise | 710 | $173.64 | $123,284.00 | (< 1%) 225.36K to 224.65K | |
| 24-Feb-20 12:18 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-20 | Payment of Exercise | 862 | $173.64 | $149,678.00 | (< 1%) 226.22K to 225.36K | |
| 24-Feb-20 12:18 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-20 | Payment of Exercise | 770 | $173.64 | $133,703.00 | (< 1%) 226.99K to 226.22K | |
| 10-Feb-20 3:37 PM View: | Charles River Laboratories ... (CRL) | 07-Feb-20 | Grant | 23,728 | -- | -- | 11% 212.85K to 236.58K | |
| 10-Feb-20 3:37 PM View: | Charles River Laboratories ... (CRL) | 07-Feb-20 | Payment of Exercise | 9,592 | $159.07 | $1,525,800.00 | (4%) 236.58K to 226.99K | |
| 11-Dec-19 10:36 AM View: | Charles River Laboratories ... (CRL) | 09-Dec-19 | Option Exercise | 24,660 | $76.67 | $1,890,680.00 | 12% 212.85K to 237.51K | |
| 11-Dec-19 10:36 AM View: | Charles River Laboratories ... (CRL) | 09-Dec-19 | Planned Option Sale | 24,660 | $144.21 | $3,556,340.00 | (10%) 237.51K to 212.85K | |
| 28-Feb-19 9:36 AM View: | Charles River Laboratories ... (CRL) | 27-Feb-19 | Payment of Exercise | 621 | $140.71 | $87,380.90 | (< 1%) 213.47K to 212.85K | (1%) |
| 28-Feb-19 9:36 AM View: | Charles River Laboratories ... (CRL) | 26-Feb-19 | Payment of Exercise | 728 | $145.31 | $105,786.00 | (< 1%) 214.2K to 213.47K | 2% |
| 26-Feb-19 10:00 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-19 | Payment of Exercise | 980 | $144.67 | $141,777.00 | (< 1%) 215.18K to 214.2K | |
| 26-Feb-19 10:00 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-19 | Payment of Exercise | 863 | $144.67 | $124,850.00 | (< 1%) 216.05K to 215.18K | |
| 26-Feb-19 10:00 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-19 | Grant | 6,145 | -- | -- | 3% 209.9K to 216.05K | |
| 01-Feb-19 1:01 PM View: | Charles River Laboratories ... (CRL) | 30-Jan-19 | Grant | 21,894 | -- | -- | 11% 196.49K to 218.39K | |
| 01-Feb-19 1:01 PM View: | Charles River Laboratories ... (CRL) | 30-Jan-19 | Payment of Exercise | 8,486 | $119.39 | $1,013,140.00 | (4%) 218.39K to 209.9K | (18%) |
| 08-Nov-18 1:29 PM View: | Charles River Laboratories ... (CRL) | 07-Nov-18 | Option Exercise | 23,356 | $59.41 | $1,387,580.00 | 12% 196.49K to 219.85K | |
| 08-Nov-18 1:29 PM View: | Charles River Laboratories ... (CRL) | 07-Nov-18 | Market Option Sale (Planned) | 23,356 | $136.00 | $3,176,420.00 | (11%) 219.85K to 196.49K | (4%) |
| 01-Mar-18 7:47 PM View: | Charles River Laboratories ... (CRL) | 28-Feb-18 | Payment of Exercise | 646 | $107.82 | $69,651.70 | (< 1%) 197.14K to 196.49K | (31%) |
| 28-Feb-18 4:02 PM View: | Charles River Laboratories ... (CRL) | 27-Feb-18 | Payment of Exercise | 621 | $108.95 | $67,657.90 | (< 1%) 197.76K to 197.14K | (29%) |
| 26-Feb-18 2:01 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-18 | Payment of Exercise | 1,033 | $109.34 | $112,948.00 | (< 1%) 198.79K to 197.76K | (29%) |
| 26-Feb-18 2:01 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-18 | Payment of Exercise | 981 | $109.34 | $107,263.00 | (< 1%) 199.77K to 198.79K | (29%) |
| 26-Feb-18 2:01 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-18 | Grant | 6,816 | -- | -- | 4% 192.96K to 199.77K | |
| 26-Jan-18 12:13 PM View: | Charles River Laboratories ... (CRL) | 24-Jan-18 | Grant | 18,604 | -- | -- | 10% 181.25K to 199.86K | |
| 26-Jan-18 12:13 PM View: | Charles River Laboratories ... (CRL) | 24-Jan-18 | Payment of Exercise | 6,901 | $106.97 | $738,200.00 | (3%) 199.86K to 192.96K | (32%) |
| 06-Oct-17 12:21 PM View: | Charles River Laboratories ... (CRL) | 05-Oct-17 | Option Exercise | 24,759 | $40.40 | $1,000,260.00 | 14% 181.25K to 206.01K | |
| 06-Oct-17 12:21 PM View: | Charles River Laboratories ... (CRL) | 05-Oct-17 | Market Option Sale (Planned) | 24,759 | $110.00 | $2,723,490.00 | (12%) 206.01K to 181.25K | (28%) |
| 13-Mar-17 3:19 PM View: | Charles River Laboratories ... (CRL) | 10-Mar-17 | Option Exercise | 41,900 | $36.62 | $1,534,280.00 | 23% 181.25K to 223.16K | |
| 13-Mar-17 3:19 PM View: | Charles River Laboratories ... (CRL) | 10-Mar-17 | Market Option Sale (Planned) | 34,593 | $89.06 | $3,080,930.00 | (16%) 223.16K to 188.56K | (58%) |
| 13-Mar-17 3:21 PM View: | Charles River Laboratories ... (CRL) | 10-Mar-17 | Market Sale (Planned) | 7,307 | $89.44 | $653,540.00 | (4%) 188.56K to 181.25K | (57%) |
| 01-Mar-17 3:12 PM View: | Charles River Laboratories ... (CRL) | 28-Feb-17 | Payment of Exercise | 697 | $89.54 | $62,409.40 | (< 1%) 181.95K to 181.25K | (57%) |
| 01-Mar-17 3:12 PM View: | Charles River Laboratories ... (CRL) | 27-Feb-17 | Payment of Exercise | 987 | $88.05 | $86,905.40 | (< 1%) 182.94K to 181.95K | (60%) |
| 28-Feb-17 8:36 AM View: | Charles River Laboratories ... (CRL) | 26-Feb-17 | Payment of Exercise | 1,093 | $88.05 | $96,238.70 | (< 1%) 184.03K to 182.94K | (60%) |
| 28-Feb-17 8:36 AM View: | Charles River Laboratories ... (CRL) | 24-Feb-17 | Grant | 7,608 | -- | -- | 4% 176.42K to 184.03K | |
| 23-Feb-17 8:40 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-17 | Payment of Exercise | 815 | $88.40 | $72,046.00 | (< 1%) 177.24K to 176.42K | (59%) |
| 02-Feb-17 9:17 AM View: | Charles River Laboratories ... (CRL) | 31-Jan-17 | Grant | 29,600 | -- | -- | 18% 160.75K to 190.35K | |
| 02-Feb-17 9:17 AM View: | Charles River Laboratories ... (CRL) | 31-Jan-17 | Payment of Exercise | 13,107 | $78.38 | $1,027,330.00 | (7%) 190.35K to 177.24K | (80%) |
| 01-Feb-17 8:32 AM View: | Charles River Laboratories ... (CRL) | 30-Jan-17 | Option Exercise | 13,950 | $37.92 | $528,984.00 | 9% 160.75K to 174.7K | |
| 01-Feb-17 8:32 AM View: | Charles River Laboratories ... (CRL) | 30-Jan-17 | Market Option Sale (Planned) | 13,950 | $78.00 | $1,088,100.00 | (8%) 174.7K to 160.75K | (81%) |
| 29-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 28-Feb-16 | Payment of Exercise | 1,134 | $73.70 | $83,575.80 | (< 1%) 161.88K to 160.75K | (91%) |
| 29-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 27-Feb-16 | Payment of Exercise | 987 | $73.70 | $72,741.90 | (< 1%) 162.87K to 161.88K | (91%) |
| 29-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-16 | Grant | 7,919 | -- | -- | 5% 154.95K to 162.87K | |
| 29-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 25-Feb-16 | Option Exercise | 34,075 | $24.80 | $845,060.00 | 22% 154.95K to 189.02K | |
| 29-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 25-Feb-16 | Market Option Sale | 34,075 | $73.02 | $2,488,150.00 | (18%) 189.02K to 154.95K | (93%) |
| 25-Feb-16 3:47 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-16 | Payment of Exercise | 2,377 | $72.53 | $172,404.00 | (2%) 157.32K to 154.95K | (94%) |
| 23-Feb-16 12:31 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-16 | Payment of Exercise | 815 | $73.31 | $59,747.60 | (< 1%) 158.14K to 157.32K | (92%) |
| 11-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 10-Feb-16 | Grant | 24,031 | -- | -- | 17% 143.3K to 167.33K | |
| 11-Feb-16 5:47 PM View: | Charles River Laboratories ... (CRL) | 10-Feb-16 | Payment of Exercise | 9,193 | $68.16 | $626,595.00 | (5%) 167.33K to 158.14K | (107%) |
| 02-Mar-15 2:34 PM View: | Charles River Laboratories ... (CRL) | 28-Feb-15 | Payment of Exercise | 1,614 | $76.67 | $123,745.00 | (1%) 144.92K to 143.3K | (84%) |
| 02-Mar-15 2:34 PM View: | Charles River Laboratories ... (CRL) | 27-Feb-15 | Grant | 6,985 | -- | -- | 5% 137.93K to 144.92K |